The aim of this study was to evaluate the diagnostic value of C-reactive protein (CRP) test in detecting neonatal septicemia.
Background
Neonatal sepsis is the leading cause of morbidity and mortality of children during the neonatal period worldwide [1] [2] [3] [4] [5] ; therefore, early diagnosis and timely treatment are needed. However, lack of clinical specificity can delay correct diagnosis. It is therefore of great importance to detect reliable biomarkers for early diagnosis of neonatal septicemia [6] . In the intensive care unit, neonatal septicemia, which is mainly caused by drug-resistant bacteria, is not only life-threatening, but may also lead to long-term sequelae [7] . C-reactive protein (CRP) is a sensitive indicator of inflammation in humans; it activates the complement system and promotes granulocyte and macrophage phagocytosis, which is the most commonly used test for diagnosis of neonatal sepsis.
Whether the diagnostic value of the CRP test is appropriate for detecting neonatal septicemia is controversial [8] [9] [10] [11] . The objective of this study was to assess the diagnostic accuracy of CRP as a single test for the early detection of neonatal sepsis. We performed a meta-analysis to assess the sensitivity, specificity, positive LR, negative LR, and diagnostic odds ratio (dOR) in patients tested by CRP.
Material and Methods

Source of material
We searched the electronic databases Cochrane Library, PubMed, Springer, MBASE, Elsevier Science Direct, and Medline (up to October 2017) using the following terms: "C-reactive protein" or "CRP" or "neonatal septicemia" or "neonatal sepsis" and "diagnosis" or "diagnostic" and "study" or "trial" or "research", limiting the search to English-language articles.
Study selection
Inclusion criteria were: (1) The internal standard mainly pertains to investigations of patients with neonatal septicemia; (2) The diagnosis of neonatal septicemia was pathologically confirmed, (3) The CRP test used for diagnosis for neonatal septicemia was included in the report; and the effect size included positive LR, sensitivity, negative LR, specificity, and dOR. We excluded reviews, case reports, and duplicate studies.
Date extraction
A standardized reporting form was used to abstract the data from each study, including study year, year of the publication, country, cutoff value, case/control, detection of CRP, TP, and FP FN TN. Data were extracted independently by 2 investigators. The results were compared and disagreements were resolved by consensus.
Evaluation of quality
Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) criteria were evaluated to determine the quality of included studies [12, 13] . The QUADAS identifies 4 key domains -"patient selection", "index test", "reference standard", and "flow and timing" -which are combined to assess the risk of bias.
Meta-analysis methods
A summarized receiver operating characteristic curve (SROC) was used to represent the performance of the diagnostic test [14] . The SROC curve includes multiple points, and the cutoff points are determined by selecting the maximum point, which is the sum of the sensitivity and the specificity [15] . The area under the curve (AUC) and exponential Q* are potential useful summaries of the curve. Based on the exact analysis of the expression, the upper limit is derived and the lower limit of the Q* is based on the limit, which is defined by the sensitivity equal to the feature point: Q* is not equal to heterogeneity [14] . We measured the asymmetry of the funnel by the natural logarithmic scale of effect size, and we used Egger linear regression [16] to assess publication bias.
We performed statistical analysis using STATA software package v.13.0 (Stata Corporation, College Station, TX, USA). All P values are bilateral. P values less than 0.05 were considered to be statistically significant.
Results
Characteristics of eligible studies
Our literature search identified 588 papers in total. The flow chart of the literature screening is shown in Figure 1 . After deleting irrelevant or duplicate papers, a total of 65 possible studies were found. After reading the abstracts, we excluded 38 articles (19 for the commentary; 11 for CRP testing; 8 did not report neonatal sepsis). The remaining 27 studies were assessed in full, and 17 of them were excluded (12 did not apply to CRP test and 5 were not available); therefore, we finally included 10 papers met our criteria.
As is shown in Table 1 , there were 10 studies [8] [9] [10] [11] [17] [18] [19] [20] [21] [22] in which sample sizes were between 26 and 1002 and CRP threshold values were between 5.82 and 10 mg/L. Quality assessment is shown in Table 2 . In combination with this metaanalysis, the accepted criterion standard for diagnosis of neonatal septicemia includes confirmation by blood culture, and thus entry 7 does not apply; CRP test results were interpreted by instruments, so entry 9 does not apply. 
Analysis of diagnostic threshold
The cutoff values used in the included studies (see Table 1 , column 4) cause differences in sensitivity and specificity, called threshold effects. A premise of our study is that there is no threshold effect in the combination of sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and other indicators. The first step in the meta-analysis of diagnostic tests is to explore the threshold effect and other heterogeneity sources. Using Meta-disc software, the Spearman correlation coefficient for the study was -0.418 and the p value was 0.229, suggesting that there was no threshold effect in this study.
Overall effects of diagnostic parameters of CRP test for neonatal septicemia in the meta-analysis
The overall results of our meta-analysis of neonatal septicemia with CRP is summarized in Table 3 . A total of 10 studies were included in the study, including 1819 participants. We used the random-effects model (Q 
Publication bias
Egger's test was performed to assess the publication bias of our study, showing there was no publication (t=-1.87, P>0.05). Neonatal sepsis, which is defined as a 30-day infection after birth, remains an important clinical syndrome and is characterized by symptomatic systemic illness. Disease progression in neonates is rapid and mortality and morbidity rates are high [10] . Clinically inoculation of premature neonates with sepsis and late-onset neonatal sepsis were divided into 3 days and 4-28 days after birth [23] . Due to diagnostic procedures, early identification of neonatal sepsis is still a global problem [8] . Studies have shown that serum procalcitonin (PCT) has high specificity and sensitivity in diagnosing early neonatal sepsis, but the cost is high.
Under normal circumstances, serum CRP levels are very low; the body of a person infected by bacteria due to WBC and other inflammatory cells releases endogenous neurotransmitters to stimulate liver cells. Synthesis of CRP occurs within 4-6 h and peaks at 36~50 h, so the inflammatory process generally begins 6-12 h after the detection of CRP [24] . Neonatal sepsis, in which bacteria invade the blood, release toxins, and stimulates systemic inflammatory response, can lead to elevated CRP.
There are several limitations of this study that should be discussed. Neonatal sepsis was not divided into early-onset and late-onset in this study. In early-onset neonatal sepsis, bacteria are derived from the intrauterine and postpartum periods, and these pathogens are concentrated. For example, in Australia, 80% of sepsis occurs within 48 h of birth and is mostly caused by B streptococcus (GBS) and gram-negative bacteria, so the time is defined at 48 h in order to guide the clinical selection of antibiotics and predict prognosis. In addition, significant between-study heterogeneities were detected in our meta-analysis, and this may have affected our results. Heterogeneity is one of the main problems of the meta-analysis method [25] , mainly due to misleading outcomes due to nonuniform data. In addition, the studies we included had differences in populations, including healthy newborns, premature children, low-birth-weight children, high-risk factors, neonatal hemolysis, intracranial hemorrhage, and wet lungs, and these differences may have affected our results. Different CRP detection methods, neonatal gestational age, and other factors may also have affected the results of this study.
Conclusions
The CRP test appears to be appropriate for use in detecting neonatal septicemia. The CRP test can help diagnose neonatal septicemia to guide rational drug use in clinical practice.
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